HALISTER: Amgen Wins EU Approval to Be First in New Cholesterol Drug Class

Amgen Wins EU Approval to Be First in New Cholesterol Drug Class

Alert: HALISTER
Source: BN (Bloomberg News)

Tickers
AMGN US (Amgen Inc)
SAN FP (Sanofi)
0629846D BB (European Commission)
REGN US (Regeneron Pharmaceuticals Inc)
3400398Z US (HHS Food & Drug Administration)

People
Sean Harper (Amgen Inc)

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283